Trevi Therapeutics (TRVI) Return on Invested Capital [ROIC] (2020 - 2023)
Trevi Therapeutics (TRVI) reported Return on Invested Capital [ROIC] of -30.19% for Q3 2023, up 2.34 percentage points from -32.54% a year earlier but down 2.21 percentage points from the prior quarter.
Powered by 
Analysis
Trevi Therapeutics (TRVI) Return on Invested Capital [ROIC] (2020 - 2023) Analysis & Trends
For FY2022, Trevi Therapeutics posted Return on Invested Capital [ROIC] of -40.32%, up 48.85 percentage points from FY2021.
- By year, Return on Invested Capital [ROIC] came in at -89.17% in FY2021 (-21.37 pp) and -67.80% in FY2020.
- Five-year quarterly Return on Invested Capital [ROIC] spans a low of -115.78% in Q3 2021 and a high of -25.17% in Q4 2022.
- Year over year, Return on Invested Capital [ROIC] has now increased in each of the last six quarters, with an average year-over-year change of +31.94 percentage points over the last eight quarters.
- The high point for year-over-year Return on Invested Capital [ROIC] in five years was Q4 2022 (a gain of 88.17 percentage points); the low point was Q4 2021 (a drop of 41.71 percentage points).
- Per Business Quant data, the three quarters before Q3 2023 came in at -27.98% (Q2 2023), -25.91% (Q1 2023) and -25.17% (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 30.89% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.57% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.28% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.52% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 23.11% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 15.60% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.11% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 12.34% |
| 10 | Trevi Therapeutics | 2.13 Bn | 1.15 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -34.18% |
| Jun 30, 2023 | -30.29% |
| Mar 31, 2023 | -26.93% |
| Dec 31, 2022 | -25.17% |
| Sep 30, 2022 | -32.54% |
| Jun 30, 2022 | -61.67% |
| Mar 31, 2022 | -111.99% |
| Dec 31, 2021 | -113.35% |
| Sep 30, 2021 | -115.78% |
| Jun 30, 2021 | -96.56% |
| Mar 31, 2021 | -80.78% |
| Dec 31, 2020 | -71.64% |
API Access
Trevi Therapeutics Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=TRVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "TRVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=TRVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();